U.S. markets open in 11 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
151.09-4.14 (-2.67%)
At close: 04:00PM EST
152.00 +0.91 (+0.60%)
Pre-Market: 09:00AM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 3/1/2024
Market Cap (intraday)
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (5 yr expected)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 3-25.42%
S&P500 52-Week Change 325.97%
52 Week High 3218.88
52 Week Low 3143.52
50-Day Moving Average 3177.75
200-Day Moving Average 3181.67

Share Statistics

Avg Vol (3 month) 3854.88k
Avg Vol (10 day) 31.91M
Shares Outstanding 5125.95M
Implied Shares Outstanding 6125.95M
Float 8125.43M
% Held by Insiders 10.36%
% Held by Institutions 195.29%
Shares Short (Feb 15, 2024) 43.99M
Short Ratio (Feb 15, 2024) 44.29
Short % of Float (Feb 15, 2024) 44.18%
Short % of Shares Outstanding (Feb 15, 2024) 43.17%
Shares Short (prior month Jan 12, 2024) 44.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin -24.08%
Operating Margin (ttm)-26.47%

Management Effectiveness

Return on Assets (ttm)-4.78%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.83B
Revenue Per Share (ttm)14.64
Quarterly Revenue Growth (yoy)31.20%
Gross Profit (ttm)N/A
EBITDA -228.12M
Net Income Avi to Common (ttm)-440.24M
Diluted EPS (ttm)-3.52
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.44B
Total Cash Per Share (mrq)19.37
Total Debt (mrq)2.68B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.08
Book Value Per Share (mrq)-1.75

Cash Flow Statement

Operating Cash Flow (ttm)104.16M
Levered Free Cash Flow (ttm)146.53M